Drug intelligence / Profile preview

FID123440

Development stage: Unknown
Administration: Ophthalmic

Overview

FID123440 appears only as an unnamed “test formulation” in a Danish ophthalmic clinical trial comparing “FID123440 testformulering og FID123437 testformulering i tør øjensygdom” (dry eye disease), with no public disclosure of its active ingredient, mechanism of action, or detailed composition.[5] Based on the available information, it is an investigational ophthalmic pharmaceutical being evaluated for dry eye disease, but its molecular modality, target, and sponsor identity are not disclosed.

Beyond the preview

Go deeper on FID123440.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on FID123440.

Explore the full profile